TaiRx, Inc. (TPEX:6580)
14.85
-0.30 (-1.98%)
Mar 24, 2026, 1:26 PM CST
TaiRx Market Cap
TaiRx has a market cap or net worth of 1.67 billion as of March 24, 2026. Its market cap has decreased by -48.67% in one year.
Market Cap
1.67B
Enterprise Value
1.24B
Revenue
15.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.85
Market Cap Chart
Since June 20, 2017, TaiRx's market cap has decreased from 3.25B to 1.67B, a decrease of -48.75%. That is a compound annual growth rate of -7.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 1.67B | -31.28% |
| Dec 31, 2025 | 2.42B | -15.03% |
| Dec 31, 2024 | 2.85B | 17.14% |
| Dec 29, 2023 | 2.44B | -27.90% |
| Dec 30, 2022 | 3.38B | -29.76% |
| Dec 30, 2021 | 4.81B | 86.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anti-Microbial Savior BioteQ | 2.21B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.18B |
| Sunny Pharmtech | 2.14B |
| TWi Biotechnology | 2.08B |
| Genomics BioSci & Tech. | 1.83B |
| Advagene Biopharma | 1.75B |
| GenMont Biotech Incorporation | 1.55B |
| NeoCore Technology | 1.40B |